What blood tests are used to monitor Lymphoma

Blood Tests for Lymphoma Monitoring

Blood tests play an important role in monitoring lymphoma during and after treatment. Here's what you should know about the main tests your care team may use:

Complete Blood Count (CBC)

The CBC measures different types of blood cells and is one of the most common monitoring tests. It includes:

• White blood cells (WBCs) – These infection-fighting cells are often abnormal in lymphoma. Your doctor tracks whether treatment is reducing abnormal lymphocytes.
• Red blood cells (hemoglobin) – Lymphoma and its treatment can cause anemia (low red blood cell count), which causes fatigue.
• Platelets – These help with blood clotting. Low platelet counts can increase bleeding risk.

Metabolic Panel and Liver/Kidney Function Tests

These tests check:

• How well your kidneys and liver are working (important since lymphoma can affect these organs, and treatments can stress them)
• Electrolytes and other chemical balances in your blood
• Lactate dehydrogenase (LDH) – an enzyme that can be elevated in lymphoma and helps assess disease burden

Immunophenotyping and Flow Cytometry

According to the NCCN Guidelines for Patients: Follicular Lymphoma, immunophenotyping is a specialized test that uses antibodies to detect specific markers (antigens) on lymphoma cells. Flow cytometry is a laboratory method that identifies and counts these specific cells in your blood or bone marrow samples. These tests help:

• Confirm lymphoma diagnosis
• Track whether abnormal lymphocytes are decreasing with treatment
• Detect early signs of relapse (cancer returning)

Molecular Residual Disease (MRD) Testing

This is an emerging, highly sensitive test that detects remaining cancer cells after treatment using circulating tumor DNA (ctDNA) – tiny fragments of cancer DNA in your bloodstream. According to recent NCCN Guidelines for B-Cell Lymphomas (December 2024), MRD testing can:

• Identify molecular recurrence before symptoms appear
• Help guide whether additional treatment is needed
• Detect relapse approximately 6-7 months earlier than imaging tests like PET/CT scans

Questions to Ask Your Care Team

1. Which blood tests will you use to monitor my specific type of lymphoma?
2. How often will I need blood work during treatment and after?
3. What do my specific test results mean for my treatment plan?
4. If my blood counts drop significantly, how will that affect my treatment schedule?
5. Are there any new tests like MRD testing that might be appropriate for my situation?

Important Context

Blood tests are typically done regularly during treatment (sometimes weekly or monthly) and then less frequently during follow-up care. Your specific monitoring schedule depends on your lymphoma type, stage, and treatment plan. While blood tests provide valuable information, they're usually combined with imaging tests (CT or PET scans) for a complete picture of how you're responding to treatment.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.